- Report
- March 2022
- 75 Pages
Global
From €857EUR$950USD£743GBP
- Report
- January 2022
- 96 Pages
Global
From €767EUR$850USD£665GBP
- Report
- April 2021
Global
From €812EUR$900USD£704GBP
- Report
- December 2020
- 64 Pages
United States
From €767EUR$850USD£665GBP
- Report
- July 2019
- 56 Pages
Global
From €722EUR$800USD£626GBP
- Report
- May 2019
- 89 Pages
Global
From €812EUR$900USD£704GBP
- Report
- October 2024
- 180 Pages
Global
From €2166EUR$2,400USD£1,877GBP
- Report
- September 2024
- 210 Pages
Global
From €2166EUR$2,400USD£1,877GBP
- Report
- August 2024
- 195 Pages
Global
From €2166EUR$2,400USD£1,877GBP
- Report
- November 2023
- 88 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Report
- October 2023
- 470 Pages
Global
From €2527EUR$2,800USD£2,189GBP
- Drug Pipelines
- August 2023
- 400 Pages
China
From €2708EUR$3,000USD£2,346GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €3791EUR$4,200USD£3,284GBP
- Report
- May 2023
- 1500 Pages
China
From €4603EUR$5,100USD£3,988GBP
- Report
- May 2022
- 510 Pages
Global
From €2708EUR$3,000USD£2,346GBP
- Report
- February 2022
- 360 Pages
United States
From €3249EUR$3,600USD£2,815GBP
- Report
- October 2021
- 72 Pages
Global
From €722EUR$800USD£626GBP
- Report
- August 2021
- 195 Pages
Global
From €2166EUR$2,400USD£1,877GBP
- Report
- April 2021
- 150 Pages
Global
From €2166EUR$2,400USD£1,877GBP
- Report
- February 2021
- 420 Pages
United States
From €2166EUR$2,400USD£1,877GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more